Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 16/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.71 |
| ▸ | HPGD | P15428 | 4/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | CASP1 | P29466 | 5/20 | 0.68 |
| ▸ | CASP7 | P55210 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323366 | 0.91 | ALDH1A1 (0.70) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3326941 | 0.89 | KDM4E (0.77) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3323430 | 0.88 | KDM4E (0.76) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3325204 | 0.87 | KDM4E (1.00) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3323056 | 0.87 | KDM4E (0.74) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL13304690 | 0.87 | KDM4E (0.74) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL12784576 | 0.86 | ALDH1A1 (0.64) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3328880 | 0.85 | KDM4E (0.65) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3325278 | 0.85 | KDM4E (0.58) | KDM4EALDH1A1HSD17B10HPGDGAA | |
| SCHEMBL3324770 | 0.84 | KDM4E (0.65) | KDM4EALDH1A1HSD17B10HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | APP, MAPT, PSEN1 | KDM4E 4115/4885ALDH1A1 2615/4885HSD17B10 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.